APTO - Aptose Biosciences Inc. (APTO) CEO William Rice on Q2 2021 Results - Earnings Call Transcript
Aptose Biosciences Inc. (APTO) Q2 2021 Earnings Conference Call August 03, 2021 05:00 PM ET Company Participants Susan Pietropaolo - Communications Representative William Rice - Chairman, President and Chief Executive Officer Rafael Bejar - Senior Vice President and Chief Medical Officer Jotin Marango - Senior Vice President, Chief Financial Officer and Chief Business Officer Conference Call Participants Ted Tenthoff - Piper Sandler & Co. John Newman - Canaccord Genuity Corp. Emily Bodnar - Cantor Fitzgerald & Co. Matthew Cross - Alliance Global Partners Matthew Biegler - Oppenheimer & Co. Inc. Presentation Operator Good afternoon. My name is Mary, and I will be your conference operator today. I would like to welcome everyone to Aptose Biosciences Conference Call for the Second Quarter ended June 30, 2021. At this time, all participants are in a listen-only mode. After the speakers' remarks, there will be a question-and-answer session. [Operator Instructions] Thank you. As
For further details see:
Aptose Biosciences Inc. (APTO) CEO William Rice on Q2 2021 Results - Earnings Call Transcript